Review top news and interview highlights from the week ending July 29, 2022.
Welcome to CGTLive’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.
The company announced successful neutrophil and platelet engraftment for the first patient dosed.
The chief of the lymphoma division and oncologist at Levine Cancer Institute discussed new CAR T-cell therapies being investigated for hematologic malignancies.
All 3 patients remained progression-free at more than 1 year post-treatment.
Susan Ruediger, founder and chief mission officer, CMT Research Foundation, discussed a new partnership with Nationwide Children’s Hospital.
Data is expected in the first quarter of 2023 for both Stargardt disease and retinitis pigmentosa.